Cannabis Market in Arkansas

Arkansas voters approved Issue 6 in November 2016, establishing a medical marijuana program and making the state the first in the Deep South to legalize cannabis in any form. The first dispensaries opened in May 2019 after a lengthy licensing process that involved numerous legal challenges. The program has since grown substantially, generating over $350 million in annual sales.

The Arkansas market operates under a limited-license framework with only 8 cultivation licenses and 40 dispensary permits statewide. This scarcity has driven up license values and created a competitive market dynamic. A recreational legalization ballot initiative (Issue 4) narrowly failed in November 2022, with opponents arguing the measure's provisions were too favorable to existing license holders. Future recreational legalization efforts remain possible but face an uncertain timeline.

Several major MSOs have established a presence in Arkansas. Green Thumb Industries (GTBIF) and Curaleaf (CURLF) both operate in the state, recognizing the market's strong per-capita sales metrics and favorable limited-license dynamics. The state's combined tax burden of approximately 10.5% is moderate by national standards, helping the legal market compete effectively against illicit sources. The Arkansas Department of Finance and Administration oversees the program through its Alcoholic Beverage Control Division, managing compliance, licensing, and enforcement.

The Arkansas cannabis market is regulated by the Arkansas Department of Finance and Administration — Alcoholic Beverage Control Division, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in Arkansas is: 6.5% state sales tax plus 4% privilege tax on medical cannabis (10.5% combined). Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in Arkansas must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the Arkansas cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $350M, and presence of 2 tracked MSOs all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with Arkansas operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.